Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

5α-reductases increase epitestosterone's effect on androgen receptors.

The research helps understand how finasteride works and aids drug development.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.